CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA Article

Grommes, Christian, Mehta, Minesh, Miller, Alexandra et al. (2020). CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA . NEURO-ONCOLOGY, 22(Supplement_2), ii36-ii36. 10.1093/neuonc/noaa215.149

cited authors

  • Grommes, Christian; Mehta, Minesh; Miller, Alexandra; Daras, Mariza; Piotrowski, Anna; Boire, Adrienne; Butler, Brittany; Stone, Jacqueline; Pentsova, Elena; Kotecha, Rupesh; Morrison, Tara; Odia, Yazmin; Mellinghoff, Ingo; Beal, Kathryn

authors

publication date

  • November 9, 2020

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • ii36

end page

  • ii36

volume

  • 22

issue

  • Supplement_2